A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention
Development and initial validation
J Am Coll Cardiol, 2004; 44:1393-1399, doi:10.1016/j.jacc.2004.06.068
Roxana Mehran, MD

OBJECTIVES: We sought to develop a simple risk score of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).

BACKGROUND: Although several risk factors for CIN have been identified, the cumulative risk rendered by their combination is unknown.

METHODS: A total of 8,357 patients were randomly assigned to a development and a validation dataset. The baseline clinical and procedural characteristics of the 5,571 patients in the development dataset were considered as candidate univariate predictors of CIN (increase ≥25% and/or ≥0.5 mg/dl in serum creatinine at 48 h after PCI vs. baseline). Multivariate logistic regression was then used to identify independent predictors of CIN with a p value <0.0001. Based on the odds ratio, eight identified variables (hypotension, intra-aortic balloon pump, congestive heart failure, chronic kidney disease, diabetes, age >75 years, anemia, and volume of contrast) were assigned a weighted integer; the sum of the integers was a total risk score for each patient.

RESULTS: The overall occurrence of CIN in the development set was 13.1% (range 7.5% to 57.3% for a low [≤5] and high [≥16] risk score, respectively); the rate of CIN increased exponentially with increasing risk score (Cochran Armitage chi-square, p < 0.0001). In the 2,786 patients of the validation dataset, the model demonstrated good discriminative power (c statistic = 0.67); the increasing risk score was again strongly associated with CIN (range 8.4% to 55.9% for a low and high risk score, respectively).

CONCLUSIONS: The risk of CIN after PCI can be simply assessed using readily available information. This risk score can be used for both clinical and investigational purposes.

 

Download full PDF of Mehran Score Article
More on Contrast Nephropathy

Using the mehran risk scoring tool to predict risk for contrast medium-induced nephropathy in patients undergoing percutaneous angiography.
Crit Care Nurse. 2011 Feb;31(1):e17-22.

Raingruber B, Kirkland-Walsh H, Chahon N, Kellermann M.

 

 

 

 

 

 


 
 
 
tags and keywords:Hemodialysis, Hemodialysis Patients, Hemodialysis nurses, Hemodialysis Technician, kidney disease, dialysis, hemo dialysis, chronic kidney disease, salt and kidney disease,kidney failure,Hemodialysis treatment, Hemodialysis complications, home Hemodialysis, nocturnal Hemodialysis, renal diet, diets for chronic kidney disease, dialysis diets, kidney diet, CKD, stages of kidney disease, kidney transplantation, necessity for Hemodialysis, Hemodialysis suppliers, Hemodialysis providers, Hemodialysis units, kidney swap, polycystic kidney disease, PKD, ESRD networks, anemia, iron, hepcidin, mortality in Hemodialysis, diabetes, NSF, NSD, Gadolinium, Omniscan, dialysis fistula, dialysis grafts, KDOQI ,KDIGO, peritoneal dialysis, PD dialysis. BNP,MDRD, CKD, ESRD, CKD-EPI, stent grafts for dialysis, dialysis treatments, mortality in Hemodialysis patients

 
 
 

For Advertising Information, please contact info@Hemodialysis.com

Follow Hemodialysis_co on Twitter 
Contact Hemodialysis.com
NKF News
Nephrology Job Board
JobOffers.com | Jobs in
Dialysis & Hemodialysis
Event Calendar: Hemodialysis and Kidney Disease

Five Things Dialysis, Kidney Disease & Hemodialysis Patients and Providers Should Question

Subscribe to the Free Hemodialysis.com Newsletter
Medical Disclaimer: Please Read
Contact email: info@Hemodialysis.com
 
Hemodialysis.com Thanks you for visiting!
Follow Hemodialysis_co on Twitter
 

Subscribe to the Free Hemodialysis.com Newsletter Privacy Policy Advertising Policy Hemodialysis.com
Mission Statement
 

The information on Hemodialysis is for informational purposes only and is not intended as specific medical advice or to be a substitute for medical advice from your physician or health care provider.
Please check with a physician if you need a diagnosis and/or for treatments as well as information regarding your specific condition.
Please read Medical Disclaimer as term of condition for usage of this website.
If you are experiencing urgent medical conditions, call 9-1-1
____________________________________________________
Hemodialysis.com Editor: Marie Benz, MD
info@hemodialysis.com

President: Robert L. Benz, MD FACP
Copyright 2013  Eminent Domains IncAll Rights Reserved.
Our Success is Linked to Yours®

Contact email: info@Hemodialysis.com